C. Anthony Hunt
C. Anthony Hunt
Professor of Bioengineering and Therapeutic Sciences
Verified email at
Cited by
Cited by
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes
F Olson, CA Hunt, FC Szoka, WJ Vail, D Papahadjopoulos
Biochimica et Biophysica Acta (BBA)-Biomembranes 557 (1), 9-23, 1979
In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
SB Noonberg, CA Hunt
US Patent 5,624,803, 1997
Liposome disposition in vivo: III. Dose and vesicle-size effects
RM Abra, CA Hunt
Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 666 (3), 493-503, 1981
Tolerance and disposition of tetrahydrocannabinol in man
CA Hunt, RT Jones
J Pharmacol Exp Ther 215 (1), 35-44, 1980
Physicochemical properties, solubility, and protein binding of Δ9 ‐tetrahydrocannabinol
ER Garrett, CA Hunt
Journal of pharmaceutical sciences 63 (7), 1056-1064, 1974
Synthesis and evaluation of a prototypal artificial red cell
CA Hunt, RR Burnette, RD MacGregor, AE Strubbe, DT Lau, N Taylor, ...
Science 230 (4730), 1165-1168, 1985
Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration
K Hirano, CA Hunt
Journal of pharmaceutical sciences 74 (9), 915-921, 1985
Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme
M Nikanjam, AR Gibbs, CA Hunt, TF Budinger, TM Forte
Journal of Controlled Release 124 (3), 163-171, 2007
Glucose transport to the brain: a systems model
AA Qutub, CA Hunt
Brain research reviews 49 (3), 595-617, 2005
Method for producing liposomes in selected size range
CA Hunt, DP Papahadjopoulous
US Patent 4,529,561, 1985
α-Tocopherol retards autoxidation and prolongs the shelf-life of liposomes
CA Hunt, S Tsang
International journal of pharmaceutics 8 (2), 101-110, 1981
Engineering Targeted In Vivo Drug Delivery. I. The Physiological and Physicochemical Principles Governing Opportunities and Limitations
CA Hunt, RD MacGregor, RA Siegel
Pharmaceutical research 3, 333-344, 1986
The metabolic disposition of radiolabeled enkephalins in vitro and in situ
FB Craves, PY Law, CA Hunt, HH Loh
Journal of Pharmacology and Experimental Therapeutics 206 (2), 492-506, 1978
Liposome disposition in vivo: effects of pre-dosing with lipsomes.
RM Abra, ME Bosworth, CA Hunt
Research communications in chemical pathology and pharmacology 29 (2), 349-360, 1980
Pharmacokinetics of Δ9-tetrahydrocannabinol in dogs
ER Garrett, CA Hunt
Journal of pharmaceutical sciences 66 (3), 395-407, 1977
Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis
W Yu, X Fang, A Ewald, K Wong, CA Hunt, Z Werb, MA Matthay, K Mostov
Molecular biology of the cell 18 (5), 1693-1700, 2007
At the biological modeling and simulation frontier
CA Hunt, GEP Ropella, TN Lam, J Tang, SHJ Kim, JA Engelberg, ...
Pharmaceutical research 26, 2369-2400, 2009
In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation
SB Noonberg, GK Scott, MR Garovoy, CC Benz, CA Hunt
Nucleic acids research 22 (14), 2830-2836, 1994
Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man
CA Hunt, RT Jones, RI Herning, J Bachman
Journal of pharmacokinetics and biopharmaceutics 9, 245-260, 1981
Liposome disposition in vivo VI: delivery to the lung
RM Abra, CA Hunt, DT Lau
Journal of pharmaceutical sciences 73 (2), 203-206, 1984
The system can't perform the operation now. Try again later.
Articles 1–20